Publikationen 2007

  1. Creutzig U, Woods WG: Acute Myelogenous Leukemia; in Bleyer WA, Barr RD, (eds): Cancer in Adolescents and Young Adults.Pediatric Oncology. Berlin, Heidelberg, New York, Springer-Verlag, 2007, pp 99-109.
  2. Creutzig U, Diekamp S, Zimmermann M, Reinhardt D: Longitudinal evaluation of early and late anthracycline cardiotoxicity in children with AML. Pediatr Blood Cancer 2007;48:651-662. www.ncbi.nlm.nih.gov/pubmed/17183582
  3. Gattenloehner S, Chuvpilo S, Langebrake C, Reinhardt D, Muller-Hermelink HK, Serfling E, Vincent A, Marx A: Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expression. Blood 2007;110:2027-2033. www.ncbi.nlm.nih.gov/pubmed/17431130
  4. Hasle H, Alonzo TA, Auvrignon A, Behar C, Chang M, Creutzig U, Fischer A, Forestier E, Fynn A, Haas OA, Harbott J, Harrison CJ, Heerema NA, van den Heuvel-Eibrink MM, Kaspers GJ, Locatelli F, Noellke P, Polychronopoulou S, Ravindranath Y, Razzouk B, Reinhardt D, Savva NN, Stark B, Suciu S, Tsukimoto I, Webb DK, Wojcik D, Woods WG, Zimmermann M, Niemeyer CM, Raimondi SC: Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study. Blood 2007;109:4641-4647. www.ncbi.nlm.nih.gov/pubmed/17299091
  5. Klusmann JH, Reinhardt D, Hasle H, Kaspers GJ, Creutzig U, Hahlen K, van den Heuvel-Eibrink MM, Zwaan CM: Janus kinase mutations in the development of acute megakaryoblastic leukemia in children with and without Down's syndrome. Leukemia 2007;21:1584-1587. www.ncbi.nlm.nih.gov/pubmed/17443226
  6. Kulozik AE, Janka-Schaub G, Creutzig U, Stahnke K, Pekrun A, Reinhardt D: Anämiediagnostik im Kindesalter; in von Schnakenburg K, Böhles H, Creutzig U, Höger P, Kiess W, Korinthenberg R, Krauspe R, Poets CF, Querfeld U, Schmaltz AA, Schmittenbecher P, Weiß M, Zimmer K-P, (eds): Leitlinien Kinderheilkunde und Jugendmedizin. Deutsche Gesellschaft für Kinder- und Jugendmedizin e.V. München, Jena, Elsevier, Urban & Fischer Verlag, 2007, pp 1-8.
  7. Langebrake C, Gunther K, Lauber J, Reinhardt D: Preanalytical mRNA stabilization of whole bone marrow samples. Clin Chem 2007;53:587-593. www.ncbi.nlm.nih.gov/pubmed/17289802
  8. Lehrnbecher T, Kaiser J, Varwig D, Ritter J, Groll AH, Creutzig U, Klingebiel T, Schwabe D: Antifungal usage in children undergoing intensive treatment for acute myeloid leukemia: analysis of the multicenter clinical trial AML-BFM 93. Eur J Clin Microbiol Infect Dis 2007;26:735-738. www.ncbi.nlm.nih.gov/pubmed/17665231
  9. Lehrnbecher T, Zimmermann M, Reinhardt D, Dworzak M, Stary J, Creutzig U: Prophylactic human granulocyte colony-stimulating factor after induction therapy in pediatric acute myeloid leukemia. Blood 2007;109:936-943. www.ncbi.nlm.nih.gov/pubmed/17008536
  10. Reinhardt D: Immunologische Diagnostik der minimalen Resterkrankung bei akuten Leukämien; in Sack U, Tárnok A, Rothe G, (eds): Zelluläre Diagnostik. Grundlagen, Methoden und klinische Anwendungen der Durchflusszytometrie. Basel, Karger, 2007, pp 1031-1046.
  11. Thiede C, Creutzig E, Reinhardt D, Ehninger G, Creutzig U: Different types of NPM1 mutations in children and adults: evidence for an effect of patient age on the prevalence of the TCTG-tandem duplication in NPM1-exon 12. Leukemia 2007;21:366-367. www.ncbi.nlm.nih.gov/pubmed/17151698
Suchen
Benutzeranmeldung